A catalytically inactive β1,4-N-acetylglucosaminyltransferase III (GnT-III) behaves as a dominant negative GnT-III inhibitor

被引:25
作者
Ihara, H [1 ]
Ikeda, Y [1 ]
Koyota, S [1 ]
Endo, T [1 ]
Honke, K [1 ]
Taniguchi, N [1 ]
机构
[1] Osaka Univ, Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2002年 / 269卷 / 01期
关键词
GnT-III; glycosyltransferase; bisecting GlcNAc; N-glycan synthesis; dominant negative effect;
D O I
10.1046/j.0014-2956.2001.02640.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta1,4-N-Acetylglucosaminyltransferase III (GnT-III) plays a regulatory role in the biosynthesis of N-glycans, and it has been suggested that its product, a bisecting GlcNAc, is involved in a variety of biological events as well as in regulating the biosynthesis of the oligosaccharides. In this study, it was found, on the basis of sequence homology, that GnT-III contains a small region that is significantly homologous to both snail beta1,4GlcNAc transferase and beta1,4Gal transferase-I. Subsequent mutational analysis demonstrated an absolute requirement for two conserved Asp residues (Asp321 and Asp323), which are located in the most homologous region of rat GnT-III, for enzymatic activity. The overexpression of Asp323-substituted, catalytically inactive GnT-III in Huh6 cells led to the suppression of the activity of endogenous GnT-III, but no significant decrease in its expression, and led to a specific inhibition of the formation of bisected sugar chains, as shown by structural analysis of the total N-glycans from the cells. These findings indicate that the mutant serves a dominant negative effect on a specific step in N-glycan biosynthesis. This type of 'dominant negative glycosyltransferase', identified has potential value as a powerful toot for defining the precise biological roles of the bisecting GlcNAc structure.
引用
收藏
页码:193 / 201
页数:9
相关论文
共 46 条
[21]   PYRIDYLAMINO SUGAR CHAIN AS AN ACCEPTOR FOR GALACTOSYLTRANSFERASE [J].
MORITA, N ;
HASE, S ;
IKENAKA, K ;
MIKOSHIBA, K ;
IKENAKA, T .
JOURNAL OF BIOCHEMISTRY, 1988, 103 (02) :332-335
[22]   The Notch signalling regulator Fringe acts in the Golgi apparatus and requires the glycosyltransferase signature motif DxD [J].
Munro, S ;
Freeman, M .
CURRENT BIOLOGY, 2000, 10 (14) :813-820
[23]   N-glycosylation is requisite for the enzyme activity and Golgi retention of N-acetylglucosaminyltransferase III [J].
Nagai, K ;
Ihara, Y ;
Wada, Y ;
Taniguchi, N .
GLYCOBIOLOGY, 1997, 7 (06) :769-776
[24]  
NARASIMHAN S, 1982, J BIOL CHEM, V257, P235
[25]  
NISHIKAWA A, 1992, J BIOL CHEM, V267, P18199
[26]   A METHOD FOR THE DETERMINATION OF N-ACETYLGLUCOSAMINYLTRANSFERASE-III ACTIVITY IN RAT-TISSUES INVOLVING HPLC [J].
NISHIKAWA, A ;
FUJII, S ;
SUGIYAMA, T ;
TANIGUCHI, N .
ANALYTICAL BIOCHEMISTRY, 1988, 170 (02) :349-354
[27]  
NISHIURA T, 1990, CANCER RES, V50, P5345
[28]  
NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D
[29]   Suppression of porcine xenoantigen expression by dominant-negative effect of α-1,3-galactosyltransferase (α-1,3-GT) splicing variants [J].
Ogawa, H ;
Kobayashi, T ;
Yokoyama, I ;
Nagasaka, T ;
Namii, Y ;
Hayashi, S ;
Kadomatsu, K ;
Muramatsu, T ;
Takagi, H .
TRANSPLANTATION PROCEEDINGS, 2000, 32 (01) :58-58
[30]   ENZYMATIC BASIS OF SUGAR STRUCTURES OF ALPHA-FETOPROTEIN IN HEPATOMA AND HEPATOBLASTOMA CELL-LINES - CORRELATION WITH ACTIVITIES OF ALPHA-1-6 FUCOSYL-TRANSFERASE AND N-ACETYLGLUCOSAMINYLTRANSFERASE-III AND N-ACETYLGLUCOSAMINYLTRANSFERASE-V [J].
OHNO, M ;
NISHIKAWA, A ;
KOKETSU, M ;
TAGA, H ;
ENDO, Y ;
HADA, T ;
HIGASHINO, K ;
TANIGUCHI, N .
INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (02) :315-317